Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Events

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>

Distance Learning, CPD and Short Courses Forum #2 Dealing with Barriers & Challenges – Marketing your Courses

Start: Mar 5, 2014 2:00:00 PM
End: Mar 5, 2014 5:00:00 PM

As the forum membership and momentum of distance learning, CPD and short courses across UCL continues to grow we are delighted to announce the details of our next event.
<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>